Long-term HBV infection of engineered cultures of induced pluripotent stem cell-derived hepatocytes.

Yang Yuan Vedant V BodkeChristine LinShang GaoJalees RehmanJisu LiSalman R Khetani

Published in: Hepatology communications (2024)

The iMPCC platform can enable the development of safe and efficacious drugs against HBV and ultimately help elucidate genotype-phenotype relationships in HBV pathogenesis.

Keyphrases

hepatitis b virus
liver failure
drug induced
liver injury
high glucose
diabetic rats
high throughput
oxidative stress